Alembic Pharmaceuticals successfully completes USFDA inspection at Baroda facility
Alembic Pharmaceuticals’ Bioequivalence Facility located at Baroda was successfully inspected by US Food & Drug Administration (USFDA) from March 6, 2017 to March 10, 2017. There were no 483s issued by USFDA at the end of the inspection.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.